Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled study to evaluate the efficacy of
ciprofloxacin versus metronidazole versus placebo in eradication of small intestinal
bacterial overgrowth (SIBO).